PRODUCTS
/
/
/
SARS-CoV-2 & Influenza A/B Antigen Combo Rapid Test
All categories

SARS-CoV-2 & Influenza A/B Antigen Combo Rapid Test

Symptoms related to COVID-19 infections can be confused with those of Influenza or even a common cold. A rapid test with differentiated detection of the multiple pathogens will reduce times and uncertainty on the initial screening of patients.
Retail price
0.0
Yuan
Market price
0.0
Yuan
Number of views:
1000
Product serial number
Quantity
-
+
Stock:
0
1
Product description


Clinical Evaluation

1.SARS-CoV-2 & Influenza A/B Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method) is used as a control reagent. A
total of 577 samples were included in this study. The following results were obtained:


2. The Influenza A Virus Antigen Detection Reagent (Colloidal Gold Method) was used as a control reagent. A total of 437
samples were included in this study. The following results were obtained:


3.The Influenza B Virus Antigen Detection Reagent (Colloidal Gold Method) was used as the control reagent. A total of 437
samples were included in this study. The following results were obtained:


Workflflow

搜索
Search
Confirm
Cancel
  • +852-3500-5196
  • info@kindmay.com
  • 32nd Floor, Block B, Building 10,
    Shenzhen Bay Science & Technology Ecological Park,
    Nanshan, Shenzhen 518057 China

Mail subscription

Username used for comment:
邮件订阅
Description:

邮件订阅

© 2007-2021 Shenzhen Kindmay Medical Co.,Ltd. All rights reserved.